SCHEMBL7863451

SCHEMBL7863451

Nc1ccc(NC(=O)c2ccccc2-c2ccccc2)cc1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 3/20 0.78
CHRNB4 P30926 3/20 0.78
CHRNA3 P32297 3/20 0.78
CHRNA4 P43681 3/20 0.78
ALDH1A1 P00352 2/20 0.68
GAA P10253 2/20 0.67
POLB P06746 2/20 0.67
TP53 P04637 1/20 0.62
HTT P42858 4/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
CYP3A4 P08684 1/20 0.58
CYP2C9 P11712 1/20 0.58
ALOX12 P18054 1/20 0.58
LMNA P02545 2/20 0.58
OPRL1 P41146 1/20 0.56
PLAU P00749 1/20 0.56
PLAT P00750 1/20 0.56
KDM4E B2RXH2 1/20 0.55
PRMT1 Q99873 2/20 0.52
SETD7 Q8WTS6 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1017796 0.88 CHRNB2 (1.00) CHRNB2CHRNB4CHRNA3CHRNA4ALDH1A1
Hydrochloric Acid SCHEMBL6801121 0.87 CHRNB2 (0.59) CHRNB2CHRNB4CHRNA3CHRNA4ALDH1A1
Hydrochloric Acid SCHEMBL29598779 0.86 CHRNB2 (0.96) CHRNB2CHRNB4CHRNA3CHRNA4ALDH1A1
SCHEMBL6795828 0.86 CHRNB2 (0.57) CHRNB2CHRNB4CHRNA3CHRNA4ALDH1A1
SCHEMBL6793972 0.84 RAB9A (0.59) CHRNB2CHRNB4CHRNA3CHRNA4ALDH1A1
SCHEMBL6791178 0.84 PTGS1 (0.67) CHRNB2CHRNB4CHRNA3CHRNA4ALDH1A1
SCHEMBL8402954 0.84 KMT2A (0.64) ALDH1A1POLBTP53HTTLMNA
SCHEMBL29201497 0.84 CHRNB2 (0.78) CHRNB2CHRNB4CHRNA3CHRNA4ALDH1A1
SCHEMBL29970845 0.84 CHRNB2 (0.78) CHRNB2CHRNB4CHRNA3CHRNA4ALDH1A1
SCHEMBL2571393 0.84 CHRNB2 (0.78) CHRNB2CHRNB4CHRNA3CHRNA4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010039348-A1 Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group AMERICAN HOME PRODUCTS CORPORATION (US) 2001-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010039348-A1 Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group CCR6, HAVCR2, BCOR CHRNB2 2579/4885CHRNB4 1829/4885CHRNA3 1593/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.